Correlation Between Mineralys Therapeutics, and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Purple Biotech, you can compare the effects of market volatilities on Mineralys Therapeutics, and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Purple Biotech.
Diversification Opportunities for Mineralys Therapeutics, and Purple Biotech
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mineralys and Purple is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Purple Biotech go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Purple Biotech
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Purple Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.47 times less risky than Purple Biotech. The stock trades about -0.05 of its potential returns per unit of risk. The Purple Biotech is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 307.00 in Purple Biotech on August 28, 2024 and sell it today you would lose (33.00) from holding Purple Biotech or give up 10.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Purple Biotech
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Purple Biotech |
Mineralys Therapeutics, and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Purple Biotech
The main advantage of trading using opposite Mineralys Therapeutics, and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stocks Directory Find actively traded stocks across global markets |